Imaging in clinical trials: a patient-led questionnaire study to assess impact of imaging regimes on patient participation
Tóm tắt
Cancer trials often incorporate intensive imaging with Magnetic Resonance Imaging (MRI) and Positron Emission Tomography with Computerised Tomography (PET/CT), which can be physically and mentally exhausting for patients. This questionnaire study aimed to determine the aspects of imaging that affect a patient’s decision to participate in clinical trials in order to inform the design of future trials that utilise imaging. This should achieve greater patient compliance and improve the patient experience. A detailed questionnaire assessing patient expectation and acceptability of imaging within clinical trials was developed in collaboration with two patient representatives. The questionnaire addressed the influence of scan type, length, frequency, scheduling, invasiveness and staff support on acceptability of imaging. It was applied to three patient groups. Group 1 consisted of patients newly recruited to studies with imaging, Group 2 consisted of previous participants in studies with imaging and Group 3 consisted of patients having imaging for clinical care. One hundred ninety six patients completed the questionnaires (Group 1:47; Group 2: 50 and Group 3: 99). The use of ionising radiation and number of scans required were identified as negative influences on decision to participate by 25% of Group 3 but only by 6% of Groups 1 and 2. Scan duration >30mins was perceived as a negative factor for decision to participate by all Groups (12–22%). Good communication provided by researchers in terms of discussing the study before and after reading study materials was a key factor in influencing decision to participate (> 50% in Groups 1 and 2 and > 20% in Group 3). Factors relating to imaging procedures within clinical trials that affect participation have been identified with communication around study materials as the key determinant. These data will be used to influence the development of future research protocols. Modification of imaging requirements within clinical trials will improve patient tolerance and acceptability and is likely to raise recruitment.
Tài liệu tham khảo
Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–68.
Gillessen S, Attard G, Beer TM, et al. Management of Patients with advanced prostate cancer: the report of the advanced prostate Cancer consensus conference APCCC 2017. Eur Urol. 2018;73:178–211.
Beets-Tan RGH, Lambregts DMJ, Maas M, et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018;28:1465–75.
Therasse P, Eisenhauer EA, Verweij J. RECIST revisited: a review of validation studies on tumour assessment. Eur J Cancer. 2006;42:1031–9.
Bychkovsky BL, Lin NU. Imaging in the evaluation and follow-up of early and advanced breast cancer: when, why, and how often? Breast (Edinburgh, Scotland). 2017;31:318–24.
Steele SR, Chang GJ, Hendren S, et al. Practice guideline for the surveillance of patients after curative treatment of colon and Rectal cancer. Dis Colon Rectum. 2015;58:713–25.
INVOLVE. Briefing notes for researchers: public involvement in NHS, public health and social care research; 2012. Go to: https://www.invoorguk/posttyperesource/why-should-members-of-the-public-be-involved-in-research Accessed 14519.
Ribeiro A, Husson O, Drey N, Thurston J, Murray I, May K. Radiation exposure awareness from patients undergoing nuclear medicine diagnostic 99mTc-bone scans and 18F-FDG PET/CT scans. In: 47th British Nuclear Medicine Society spring meeting. Oxford: BNMS; 2019.
May K, Braun J, Ribeiro A, Morgan V, Koh D-M. Whole body magnetic resonance imaging – the patient perspective. In: 14th UK clinical research facilities network annual conference. Leeds: UKCRFN; 2018.
Thornton RH, Dauer LT, Shuk E, et al. Patient perspectives and preferences for communication of medical imaging risks in a cancer care setting. Radiology. 2015;275:545–52.
May K, Lee M, Jefford M, et al. Embedding imaging in clinical trials – a questionnaire study assessing the impact of imaging regimes on patient participation. In: 12th UK clinical research facilities network annual conference. Manchester: UKCRFN; 2018.